Experimental cisplatin neuronopathy in rats and the effect of retinoic acid administration

Journal of Neuro-Oncology

Volumn 36, Issue 1, 1998, Pages 31-40

  Tredici, Giovanni ^a   Tredici, Stefano ^a   Fabbrica, Davide ^a   Minoia, Claudio ^b   Cavaletti, Guido ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b IRCCS   (Italy)

Author keywords

Cisplatin neuronopathy; Dorsal root ganglia; Nerve conduction velocity; Nerve recovery; Neuroprotection; Retinoic acid

Indexed keywords

ANTINEOPLASTIC AGENT; ANTIOXIDANT; CISPLATIN; RETINOIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; ELECTROPHYSIOLOGY; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; MORPHOMETRICS; NERVE CELL; NERVE CONDUCTION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; NUCLEOLUS; PAIN; PERIPHERAL NERVOUS SYSTEM; RAT; SPINAL GANGLION;

ANIMALS; BODY WEIGHT; CISPLATIN; FEMALE; GANGLIA, SPINAL; INJECTIONS, INTRAPERITONEAL; NEURAL CONDUCTION; PERIPHERAL NERVOUS SYSTEM DISEASES; RANDOM ALLOCATION; RATS; RATS, WISTAR; TAIL; TRETINOIN;

EID: 0031744762     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005756023082     Document Type: Article

References (55)

1. Mollman JE: Cisplatin neurotoxicity. N Engl J Med 322: 126-127, 1990
2. Cavaletti G, Marzorati L, Bogliun G, Colombo N, Marzola M, Pittelli MR, Tredici G : Cisplatin peripheral neurotoxicity is not only total dose but also single dose intensity-dependent. Cancer 69: 203-207, 1992
3. Thompson SW, Dawis LE, Kornfield M, Hilgers RD, Standeffer JC: Cisplatin neuropathy: clinical, electrophysiologic, morphologic, and toxicologic studies. Cancer 54: 1269-1275, 1984
4. Tomiwa K, Nolan C, Cavanagh JB : The effect of cisplatin on the rat spinal ganglia: a study by light and electron microscopy and by morphometry. Acta Neuropathol 69: 295-308, 1986
5. Müller LJ, Geritsen van der Hoop R, Moorer-van Delft C, Gispen WH, Roubos EW: Morphological and electrophysiological study of the effects of cisplatin and Org. 2766 on rat spinal ganglion neurons. Cancer Res 50: 2437-2442, 1990
6. Cavaletti G, Tredici G, Marmiroli P, Petruccioli MG, Barajon I, Fabbrica D: Morphometric study of the sensory neuron and peripheral nerve changes induced by chronic cisplatin (D D P) administration in rats. Acta Neuropathol 84: 364-371, 1992
7. Harder HC, Rosenberg G: Inhibitory effects of antitumor platinum compounds on DNA, RNA and protein synthesis in mammalian cells in vitro. Int J Cancer 6: 207-216, 1970
8. Pinto AL, Lippard SJ: Binding of the antitumor drug cisdiamminedichloroplatinum (II) (cisplatin) to DNA. Biochem Biophys Acta 780: 167-180, 1985
9. Huang H, Zhu L, Reid BR, Drobny GP, Hopkins PB: Solution structure of a cisplatin induced DNA interstrand cross-link. Science 270: 1842-1845, 1995
10. Cece R, Petruccioli MG, Pizzini G, Cavaletti G, Tredici G: Ultrastructural aspects of D RG satellite cell involvement in experimental cisplatin neuronopathy. J Submicrosc Cytol Pathol 27: 417-425, 1995
11. Apfel SC, Arezzo JC, Lipson LA, Kessle JA: Nerve growth factor prevents experimental cisplatin neuropathy. Ann Neurol 31: 76-80, 1992
12. Windebank AJ, Smith AG, Russell JW: The effect of nerve growth factor, ciliary neurotrophic factor, and ACTH analogs on cisplatin neurotoxicity in vitro. Neurology 44: 488-494, 1994
13. Konings PNM, Makkink WK, van Delft AML, Ruigt GSF: Reversal by NGF of cytostatic drug-induced reduction of neurite outgrowth in rat dorsal root ganglia in vitro. Brain Res 640: 195-204, 1994
14. Gao W-Q, Dybdal N, Shinsky N, Murnane A, Schmelzer C, Siegel M, Keller G, Hefti F, Phillips HS, Winslow JW: Neurotrophin-3 reverses experimental cisplatin-induced peripheral sensory neuropathy. Ann Neurol 38: 30-37, 1995
15. Malgrange B, Delree P, Rigo JM, Baron H, Moonen G: Image analysis of neuritic regeneration by adult rat dorsal root ganglion neurons in culture: quantification of the neurotoxicity of anticancer agents and of its prevention by nerve growth factor or basic fibroblast growth factor but not brain-derived neurotrophic factor or neurotrophin-3. J Neurosci Methods 53: 111-122, 1994
16. Gerritsen van der Hoop R, De Koning P, Boven E, Neijt JP, Jennekens FGI, Gispen WH: Efficacy of the neuropeptide O R G.2766 in the prevention and treatment of cisplatin-induced neurotoxicity in rats. Eur J Cancer Clin Oncol 24: 637-642, 1988
17. Hamers FPT, Pette C, Bravenboer B, Vecht CJ, Neijt JP, Gispen WH: Cisplatin-induced neuropathy in mature rats: effects of the melanocortin-derived peptide O R G 2766. Cancer Chemother Pharmacol 32: 162-166, 1993
18. Gerritsen van der Hoop R, Hamers FPT, Neijt JP, Veldman H, Gispen WH, Jennekens FGI: Protection against cisplatin induced neurotoxicity by O R G 2766: histological and electrophysiological evidence. J Neurol Sci 126: 109-115, 1994
19. 4-9 analogue against the toxic effects of cisplatin and taxol on sensory neurons and glial cells in vitro. J Neurosci Res 39: 178-185, 1994
20. Di Re F, Bohm S, Oriana S, Spatti GB, Zunino F: Efficacy and safety of high-dose cisplatin and cyclophosphamide with glutathione protection in the treatment of bulky advanced epithelial ovarian cancer. Cancer Chemother Pharmacol 25: 355-360, 1990
21. Tedeschi M, De Cesare A, Oriana S, Perego P, Silva A, Venturino P, Zunino F: The role of glutathione in combination with cisplatin in the treatment of ovarian cancer. Cancer Treat Rev 18: 253-259, 1991
22. Hamers FPT, Brakkee JH, Cavalletti E, Tedeschi M, Marmonti L, Pezzoni G, Neijt JP, Gispen WH: Reduced glutathione protects against cisplatin-induced neurotoxicity in rats. Cancer Res 53: 544-549, 1993
23. Cavaletti G, Minoia C, Schieppati M, Tredici G: Protective effects of glutathione on cisplatin neurotoxicity in rats. Int J Rad Oncol Biol Phys 29: 771-776, 1994
24. Tredici G, Cavaletti G, Petruccioli MG, Fabbrica D, Tedeschi M, Venturino P: Low-dose glutathione administration in the prevention of cisplatin-induced peripheral neuropathy in rats. Neurotoxicol 15: 701-704, 1994
25. Cascinu S, Cordella L, Del Ferro E, Fronzoni M, Catalano G: Neuroprotective effect of reduced glutathione on cisplatin-based chemotherapy in advanced gastric cancer: a randomized double-blind placebo-controlled trial. J Clin Oncol 13: 26-32, 1995
26. Hamers FPT, Gerritsen van der Hoop R, Steerenburg PA, Neijt JP, Gispen WH: Putative neurotrophic factors in the protection of cisplatin-induced peripheral neuropathy in rats. Toxicol Appl Pharmacol 111: 514-522, 1991
27. Wuarin L, Sidell N, de Vellis J: Retinoids increase perinatal spinal cord neuronal survival and astroglial differentiation. Int J Dev Neurosci 8: 317-326, 1990
28. Wuarin L, Sidell N: Differential susceptibilities of spinal cord neurons to retinoic acid-induced survival and differentiation. Dev Biol 144: 429-435, 1991
29. van Holst A, Rodriguez-Tabar A, Michaille JJ, Dhouailly D, Bäckström A, Ebendal T, Rohrer H: Retinoic acid-mediated increase in TrkA expression is sufficient to elicit NGF-dependent survival of sympathetic neurons. Mol Cell Neurosci 6: 185-198, 1995
30. Wion D, Houlgatte R, Barbot N, Barrand P, Dicou E, Brachet P: Retinoic acid increases the expression of NGF gene in mouse L cells. Biochem Biophys Res Commun 149: 510-514, 1987
31. Haskell BE, Stach RW, Werrbach-Perez K, Perez-Polo JR: Effect of retinoic acid on nerve growth factor receptors. Cell Tissue Res 247: 67-73, 1987
32. Vogel KS: Development of trophic interactions in the vertebrate peripheral nervous system. Mol Neurobiol 7: 363-382, 1993
33. Carswell S: The potential for treating neurodegenerative disorders with NGF-inducing compounds. Exp Neurol 124: 36-42, 1993
34. Rodriguez-Tebar A, Rohrer H : Retinoic acid induced NGF-dependent survival response and high-affinity NGF receptors in immature chick sympathetic neurons. Development 112: 813-820, 1991
35. Kaplan D R, Matsumoto K, Lucarelli E, Thiele CJ: Induction of TrkB by retinoic acid mediates biologic responsiveness to B D N F and differentiation of human neuroblastoma cells. Eukaryotic Signal Transduction Group. Neuron 11: 321-331, 1993
36. KobayashiM, Kurihara K, Matsuoka I: Retinoic acid induces B D N F responsiveness of sympathetic neurons by alteration of Trk neurotrophin receptor expression. FEBS Lett 356: 60-65, 1994
37. Hennekens CH, Mayrent SL, Willett W: Vitamin A, Carotenoids and retinoids. Cancer 58: 1837-1841, 1986
38. Das NP: Effects of vitamin A and its analogs on nonenzymatic lipid peroxidation in rat brain mitochondria. J Neurochem 52: 585-588, 1989
39. Jackson GR, Morgan BC, Werrbach-Perez K, Perez-Polo JR: Antioxidant effect of retinoic acid on PC12 rat pheochromocytoma. Int J Dev Neurosci 9: 161-170, 1991
40. Dragsted LO, Strube M, Larsen JC: Cancer-protective factors in fruits and vegetables: biochemical and biological background. Pharmacol Toxicol 72 (Suppl 1) 116-135, 1993
41. Gerster H : Anticarcinogenic affect of common carotenoids. Int J Vitam Nutr Res 63: 93-121, 1993
42. Cece R, Petruccioli MG, Cavaletti G, Barajon I, Tredici G: An ultrastructural study of neuronal changes in dorsal root ganglia (DRG) of rats after chronic cisplatin administrations. Histol Histopathol 10: 837-845, 1995
43. Boyer M, Raghavan D, Haris PJ, Liecht J, Bleasel A, Walsh C: Lack of late toxicity in patients treated with cisplatin-containing combination chemotherapy for metastatic testicular cancer. J Clin Oncol 8: 21-26, 1990
44. Hovestadt A, van der Burg MEL, Verbiest HBC, van Putten WLJ, Vecht CJ: The course of neuropathy after cessation of cisplatin treatment, combined with Org2766 or placebo. J Neurol 239: 143-146, 1992
45. Schmidt Y, Unger JW, Bartke I, Reiter R: Effect of nerve growth factor on peptide neurons in dorsal root ganglia after taxol or cisplatin treatment and in diabetic (db/db) mice. Exp Neurol 132: 16-23, 1995
46. Levi J, Jacobs C, Kalman SM, McTingue M, Weiner MW: Mechanisms of cisplatinum nephrotoxicity: 2. Effects of sulfhydril groups in rat kidneys. Pharmacol Exp Ther 213: 545-550, 1980
47. Rosenberg B: Fundamental studies with cisplatin. Cancer 55: 2303-2316, 1985
48. Hegedüs L, van der Vijgh WJF, Klein I, Kerpel-Fronius S, Pinedo HM: Chemical reactivity of cisplatin bound to human plasma proteins. Cancer Chemother Pharmacol 20: 211-212, 1987
49. Tay LK, Bregman CL, Masters BA, Williams PD: Effect of cis-diamminedichloroplatinum (II) on rabbit kidney in vivo and on rabbit renal proximal tubule cells in culture. Cancer Res 48: 2538-2543, 1988
50. Parti R, Wolf W: Quantitative subcellular distribution of platinum in rats tissues following i.v. bolus and i.v. infusion of cisplatin. Cancer Chemother Pharmacol 26: 188-192, 1990
51. Russell JW, Windebank AJ, McNiven MA, Brat DJ, Brimijoin WS: Effect of cisplatin and ACTH4-9 on neural transport in cisplatin induced neurotoxicity. Brain Res 676: 258-267, 1995
52. Barajon I, Bersani M, Quartu M, Del Fiacco M, Cavaletti G, Holst JJ, Tredici G: Neuropeptides and morphological changes in cisplatin-induced dorsal root ganglion neuronopathy. Exp Neurol 138: 93-104, 1996
53. Olson Y: Vascular permeability in the peripheral nervous system. In: Dyck PJ, Thomas PK, Lambert EH, Bunge R (eds) Peripheral Neuropathy. Saunders, Philadelphia 579-597, 1984
54. Allen DT, Kiernan JA: Permeation of protein from the blood into peripheral nerves and ganglia. Neurosci 59: 755-764, 1994
55. Cavaletti G, Tredici G, Pizzini G, Minoia C: Tissue platinum concentrations and cisplatin schedules. Lancet ii: 1003, 1990